MarkJosephKellyMD

Genitourinary Oncology

Attending Surgeon Miami Cancer Institute 8900 N. Kendall Drive Miami, FL 33176

Overview of Dr. Kelly

Dr. Mark Kelly is urological oncologist in Miami, Florida, affiliated with the Miami Cancer Institute of Baptist Hospital.

His clinical research is focused on the current management of prostate cancer detection and treatment using biomarkers and the image-guided paradigm offered by multiparametric MRI and PSMA Imaging.

His patient centered goals are threefold:

1. To better detect those prostate cancers that should be detected,
2. Protect those men with no prostate cancer or indolent prostate cancer from unnecessary invasive interventions, and
3. Determine the safety, utility and durability of focal ablative treatment of men with index lesion only prostate cancer.

Office
8900 N Kendall Dr
Miami, FL 33176
Book by Phone+1(786) 983-6021

Fax+1 786-533-9353

Education & Training

Kaiser Permanente Southern California (Los Angeles)Residency, Urology, 1986 - 1990
Kaiser Permanente Southern California (Los Angeles)Residency, Surgery, 1984 - 1986
Albert Einstein College of MedicineClass of 1984
State University of New York (SUNY) at BuffaloB.A., Cell and Molecular Biology, 1974 - 1978

Certifications & Licensure

FL State Medical License 2022 - 2026
CA State Medical License 1985 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2022
Top Doctors:Southern California Castle Connolly, 2014
Top Doctors in Southern California Castle Connolly Selection, 2015
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
America's Top Surgeons
Top Urologists in America U.S. News & World Report
America's Top Urologists Consumer Research Council
LA's Top Doctors Los Angeles Magazine
Who's Who in American Medicine Marquis
Patient's Choice Award American Registry
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Publications & Presentations

PubMed

8 citations
Recognition of histone H3 methylation states by the PHD1 domain of histone demethylase KDM5A
James E. Longbotham, Mark J. S. Kelly, Danica Galonić Fujimori
ACS Chemical Biology. 2021-02-23
41 citations
Expanding the space of protein geometries by computational design of de novo fold families
Xingjie Pan, Michael C. Thompson, Yang Zhang, Lin Liu, James S. Fraser
Science. 2020-08-28
44 citations
Single-Cell RNA Profiling Reveals Adipocyte to Macrophage Signaling Sufficient to Enhance Thermogenesis.
Felipe Henriques, Alexander H. Bedard, Adilson L. Guilherme, Mark J. S. Kelly, Jingyi Chi
Cell Reports. 2020-08-04

Lectures

"Current Management of Renal Angiomyolipoma"
Santa Monica, CA - 1/12/2015
Update of NCCN Management of Pathological T2 Bladder Cancer.
Santa Monica, CA - 1/12/2015
The Evaluation and Management of Urinary Retention in the Acute Care Setting.
Santa Monica, CA - 1/11/2015
Active Surveillance for Men with Low-Risk Adenocarcinoma of the Prostate. "Who Is a Candidate for Surveillance, Who Is Not?"
1/11/2014
Reconciling the R.E.N.A.L. Nephrometry Tool and the updated NCCN Management Guidelines for Kidney Cancer. "Upholding Oncological Principles and Avoiding Chronic Kidney...
1/11/2014
Squamous Cell Carcinoma of the Penis. Natural History, Epidemiology, Diagnosis, Staging and Management.
1/10/2014
The use of multiparimetric MRI Imaging in the Management of Clinically Localized Prostate Cancer.
1/8/2014
Join now to see all